William Blair & Company
LLY icon

William Blair & Company’s Eli Lilly LLY Stock Holding History

William Blair & Company’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100
Closed -$7K – 1487
2016
Q4 		$7K Buy
+100
New +$7.45K ﹤0.01% 1376

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

William Blair & Company's LLY Position: Q1 2026 in Review

William Blair & Company reduced its Eli Lilly (LLY) stake by 0.24% in Q1 2026, selling an estimated $789K and leaving 324,018 shares worth $298M. The position accounts for 0.85% of the portfolio, ranked #20.

William Blair & Company first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $349M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • William Blair & Company held 324,018 shares of Eli Lilly worth $298M as of Q1 2026.
  • William Blair & Company sold 778 Eli Lilly shares in Q1 2026, an estimated $789K.
  • Eli Lilly made up 0.85% of William Blair & Company's portfolio in Q1 2026, its #20 holding.
  • William Blair & Company first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • William Blair & Company's Eli Lilly position peaked at $349M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.